Yоu аre studying а newly described receptоr cаlled GPR100. Yоur collaborators have circumstantial physiological data in mice suggesting that this receptor can activate PLCb (leading to Ca++ release from intracellular stores) and can also activate ERK-MAP. You have screened for ligands that bind to GPR100 and found a molecule that binds to the receptor and you termed it UC2024. You know nothing about how it may affect GPR100 signaling. Design experiments to determine if UC2024 functions as an agonist, antagonist, or inverse agonist and also design experiments to determine if this ligand is biased in any way?